Skip to content

A Comparative Study of Two Ayurvedic Basti Therapies for Spastic Cerebral Palsy with Baladi Ghrita as Supportive Treatment

Comparative Evaluation of Dhanwantara taila Matrabasti and Chaturbhadrakalpa Basti Protocols in Spastic Cerebral Palsy with Baladi Ghrta as Adjunct Therapy: An Open-Label, Randomized Two-Arm Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104954
Enrollment
58
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G809- Cerebral palsy, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 2 to 12 years, of any gender, with a clinical diagnosis of spastic cerebral palsy established by standard neurological and developmental assessments and exhibiting a minimum spasticity score of Modified Ashworth Scale (MAS) more than 1 in at least one affected limb joint. 2. Children who are deemed eligible for Basti therapy (Basti Yogya) as per Ayurvedic assessment. 3. Stable medical condition enabling participation in therapeutic interventions. 4. Informed consent/ assent obtained from parent or legal guardian.

Exclusion criteria

Exclusion criteria: 1. Progressive neurological or neurodegenerative disorders. 2. Active systemic infections or inflammatory diseases. 3. Intractable epilepsy or uncontrolled seizure disorders. 4. Local skin infections or eruptions at sites relevant to intervention (e.g., bandaging sites). 5. Acute illnesses or unstable medical conditions interfering with study participation. 6. Major congenital malformations including significant cardiac anomalies (e.g., congenital heart disease). 7. Fixed joint contractures limiting intervention applicability. 8. Orthopedic surgery, casting, or splinting within the past 12 months. 9. Caregivers unwilling or unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Reduction in spasticity, as measured by the Modified Ashworth Scale.Timepoint: Time Frame: Baseline Day 0, day 45 and Day 60.

Secondary

MeasureTime frame
Improvement in joint range of motion (elbow, wrist, knee, ankle), measured using a digital goniometer. Improvement in gross motor function, assessed by the Gross Motor Function Classification System (GMFCS). Improvement in gait parameters and functional motor performance, evaluated using 3D gait analysis (if feasible). Reduction in medial gastrocnemius stiffness, assessed via sono-elastography (if feasible). Improvement in postural stability, measured using the BTracks balance assessment system, thereby validating its clinical utility in rehabilitation monitoring. Significant improvement in the quality of life of children with cerebral palsy as assessed by the Cerebral Palsy Quality of Life (CP QOL) scale. Timepoint: day zero, Day 45 and Day 60

Countries

India

Contacts

Public ContactDr Mahapatra Arun Kumar

All India Institute of Ayurveda

ayuarun@gmail.com8506821947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026